Get started
LOBE SCIENCES LTD.LOBE SCIENCES LTD.LOBE SCIENCES LTD.

LOBE SCIENCES LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

LOBE chart

Key stats

Market capitalization
‪1.17 M‬CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.035CAD
Net income
‪−4.71 M‬CAD
Revenue
‪840.53 K‬CAD
Shares float
‪64.49 M‬
Beta (1Y)
3.60

About LOBE SCIENCES LTD.

Sector
Process Industries
Industry
Agricultural Commodities/Milling
CEO
Philip J. Young
Website
lobesciences.com
Headquarters
Vancouver
Founded
2010
FIGI
BBG00PD5TC64
Lobe Sciences Ltd. is a biopharmaceutical company, which engages in the discovery and development of transformative medicines to treat rare diseases. It is involved in drug research and development using non-hallucinatory doses of stabilized psilocin-based compounds to address unmet medical needs in orphan neurological therapeutic applications. The company was founded on May 13, 2010 and is headquartered in Vancouver, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LOBE is 0.015 CAD — it has decreased by 25.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange LOBE SCIENCES LTD. stocks are traded under the ticker LOBE.
LOBE stock is 33.33% volatile and has beta coefficient of 3.60. Check out the list of the most volatile stocks — is LOBE SCIENCES LTD. there?
Yes, you can track LOBE SCIENCES LTD. financials in yearly and quarterly reports right on TradingView.
LOBE net income for the last quarter is ‪−568.03 K‬ CAD, while the quarter before that showed ‪−1.38 M‬ CAD of net income which accounts for 58.71% change. Track more LOBE SCIENCES LTD. financial stats to get the full picture.
No, LOBE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LOBE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LOBE SCIENCES LTD. stock right from TradingView charts — choose your broker and connect to your account.
LOBE reached its all-time high on Jun 19, 2019 with the price of 1.770 CAD, and its all-time low was 0.015 CAD and was reached on Oct 4, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LOBE SCIENCES LTD. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LOBE SCIENCES LTD. stock shows the sell signal. See more of LOBE SCIENCES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LOBE SCIENCES LTD. EBITDA is ‪−1.89 M‬ CAD, and current EBITDA margin is −394.47%. See more stats in LOBE SCIENCES LTD. financial statements.